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Bacterial fermentation platform 
for producing artificial aromatic 
amines
Shunsuke Masuo1, Shengmin Zhou1, Tatsuo Kaneko2 & Naoki Takaya1
Aromatic amines containing an aminobenzene or an aniline moiety comprise versatile natural and 
artificial compounds including bioactive molecules and resources for advanced materials. However, 
a bio-production platform has not been implemented. Here we constructed a bacterial platform for 
para-substituted aminobenzene relatives of aromatic amines via enzymes in an alternate shikimate 
pathway predicted in a Pseudomonad bacterium. Optimization of the metabolic pathway in Escherichia 
coli cells converted biomass glucose to 4-aminophenylalanine with high efficiency (4.4 g L−1 in fed-batch 
cultivation). We designed and produced artificial pathways that mimicked the fungal Ehrlich pathway 
in E. coli and converted 4-aminophenylalanine into 4-aminophenylethanol and 4-aminophenylacetate 
at 90% molar yields. Combining these conversion systems or fungal phenylalanine decarboxylases, 
the 4-aminophenylalanine-producing platform fermented glucose to 4-aminophenylethanol, 
4-aminophenylacetate, and 4-phenylethylamine. This original bacterial platform for producing artificial 
aromatic amines highlights their potential as heteroatoms containing bio-based materials that can 
replace those derived from petroleum.
The production of bulk materials and fuels from renewable resources is prerequisite for constructing sustainable 
low-carbon societies that can overcome global environmental issues and limited fossil fuel resources. Aromatic 
amines that are characterized by an amino-substituted benzene (aniline) moiety (referred to hereinafter as AA) 
serve as resources from which to develop dyes, rubbers, plastics and conductive polymers1,2, and they are impor-
tant in a broad range of industries. Most living organisms produce the AA, 4-aminobenzoic acid, as a biosynthetic 
precursor of folate, which is an essential cofactor that is also a dietary supplement3. Some AA are intermediates of 
antibacterial chloramphenicol, pristinamycin4,5 and other drugs, and developing a repertoire of AA is important 
from a pharmaceutical standpoint. Due to such substantial demand, various commercial AA have been synthe-
sized by petroleum chemistry, whereas none has been derived from biomass, which limits the molecular design 
of practical bio-derived products based on AA.
Aromatic amines are significant in the production of advanced polymer materials including functional and/
or high-performance plastics. The amine group and the aromatic moiety of AA induce nucleophilic reactivity and 
excellent thermomechanical performance, respectively6. Aromatic amines are polycondensed with carbonyl com-
pounds to generate aromatic polyamides, polyimides, polyazoles, polyurea and polyazomethines. When poly-
condensed with aromatic acids, AA generate super-engineering plastics with extremely high thermomechanical 
properties7,8. These include poly(p-phenylene terephthalamide (KevlarTM) and poly(4,4′ -oxydiphenylene pyrom-
ellitimide) (KaptonTM) that serve as thermostable materials in fabric for body armor and other flame-retardant 
materials, fiber-reinforced plastics for electronic devices, vehicle bodies and anti-pressure cylinders7–9. The 
applications of super-engineered plastics are diversifying, and this is increasing the annual global production 
of AA-derived plastics to around 100,000 tons. Global production of aromatic polyamides accounts for several 
hundreds of millions of US dollars, which indicates the size of the contribution of AA to both the economy and 
society.
The production of aromatic polyamides and polyimides requires aromatic carboxylic acids and/or AA as 
building blocks. Whereas aromatic carboxylic acids (such as terephthalic acid) have been derived from bio-
mass10,11, AA have not, and this has precluded the development of fully bio-oriented aromatic polyamides and 
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polyimides. Our recent microbial production of the non-natural AA, 4-aminocinnamic acid (4ACA), from 
4-aminophenylalanine (4APhe), which is an intermediate of the chloramphenicol and pristinamycin biosynthe-
sis pathway4,5, followed by synthesis of ultra-high-performance polyimide is the exception12. Not only 4ACA, but 
also other AA derived from biomass would serve as innovative monomers for synthesizing bio-AA plastics, and 
their environmental impact should be enormous, considering that they would replace polyamides and polyimides 
derived in bulk from petroleum.
Only a few natural pathways of AA biosynthesis have been documented. This causes considerable difficulty 
when trying to custom-design pathways to synthesize various AA. The 4ACA production system ferments 
4APhe via antibiotic-synthesizing enzymes produced by recombinant Escherichia coli13, and then a bacterium 
producing phenylalanine ammonia lyase converts 4APhe to 4ACA (Fig. 1)12. This study identified a novel 
4APhe synthetic gene cluster from Pseudomonas fluorescens, which in accordance with the optimization of host 
E. coli metabolism enables 35-fold more 4APhe production than that generated in a previous study that used 
antibiotic-synthesizing enzymes from Streptomyces bacteria (0.13 g L−1)13. Recombinant E. coli strains produc-
ing sets of phenylalanine-catabolic enzymes fermented glucose to a series of artificial 4-amino-substituted AA 
including 4-aminophenylacetate (4APAA), 4-aminophenylacetaldehyde, 4-aminophenylethanol (4APE), and 
4-aminophenylethylamine (4APEA) (Fig. 1). Bio-aromatic polyamide and polyimides can be developed from all 
of these compounds. The platform for synthesizing bio-derived AA constructed in the present study increases the 
potential for producing a range of bio-based AA materials for bio-polymers and other applications.
Results
Novel P. fluorescens papABC genes optimize 4APhe production. We and another group expressed 
the Streptomyces venezuelae and S. pristinaespiralis genes encoding 4-amino-4-deoxychorismate synthase (PapA), 
4-amino-4-deoxychorismate mutase (PapB), and 4-amino-4-deoxyprephenate dehydrogenase (PapC) in recom-
binant E. coli and synthesized 4APhe13. These enzymes convert cellular chorismate to 4-aminophenylpyruvate4,5, 
which endogenous aminotransferases in E. coli subsequently convert to 4APhe13. Homology searches identified 
similar amino acid sequences to S. venezuelae PapA, PapB and PapC in predicted proteins of P. fluorescens SBW25 
(Fig. 2a) encoded by PFLU_1771 (pfpapA), PFLU_1772 (pfpapB) and PFLU_1770 (pfpapC), and their entire 
amino acid sequences have 44%, 28% and 34% similarity, respectively (Fig. 2a, Supplementary Fig. 1). These genes 
are clustered in the P. fluorescens SBW25 genome like their Streptomyces counterparts4,5, where they might con-
stitute an operon. We constructed an artificial operon comprising the T7lac gene promoter followed by pfpapB, 
pfpapA, and pfpapC in that order (plasmid 1 in Fig. 2a), and introduced it into E. coli NST37(DE3)/ΔpheLA. The 
strain lacks a pheLA locus in the leader peptide for pheA expression (pheL) and chorismate mutase (pheA) that 
competes with the substrate chorismate with PapA. The strain harboring the operon generated 0.43 g L−1 4APhe 
in minimal medium with glucose whereas all strains expressing only pfpapA, pfpapAB (Fig. 2b), pfpapBC, or the 
set of pfpapA and pfpapC (Supplementary Fig. 2) did not. These results indicated that pfpapABC participates in 
4APhe synthesis.
We analyzed the ability of a series of pfpapABC expression plasmids to produce 4APhe. The appropriate genes 
were introduced into pET-duet1, pRSF-duet1 and pCDF-duet1, which were maintained as ~40, 20~40, and 
> 100 copies/cell, respectively14, and expressed under the T7lac promoter (Fig. 2a). The strains harboring sets of 
Figure 1. Artificial pathways producing aromatic amines. AAAD, aromatic amino acid decarboxylase; ADH, 
aldehyde dehydrogenase; ALDH, alcohol dehydrogenase; AT, aminotransferase; PAL, phenylalanine ammonia 
lyase; PapA, 4-amino-4-deoxychorismate synthase; PapB, 4-amino-4-deoxychorismate mutase; PapC, 4-amino-
4-deoxyprephenate dehydrogenase; PDC, phenylpyruvate decarboxylase. Host cell genes encoded aroG4fbr, 
feedback resistant isozyme of DAHP synthase; pps, PEP synthase; tktA, transketolase.
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pET-pfpapA and pCDF-pfpapBC, and pCDF-pfpapA and pET-pfpapBC (plasmids 3, 8 and 5, 6 in Fig. 2c, respec-
tively) produced the most 4APhe, up to 0.53 g L−1. We selected NST37(DE3)/Δ pheLA harboring pET-pfpapA and 
pCDF-pfpapBC (NDP strain), which produced 4APhe, and optimized its 4APhe production.
Metabolic engineering E. coli for efficient AA production. We overexpressed the transketolase gene 
(tktA) under the control of the T7lac gene promoter in the NDP strain and found that it produced 1.2-fold more 
4APhe than the parent strain (Fig. 3a), which is consistent with reports that its overexpression increases the avail-
ability of erythrose 4-phosphate (E4P) for 3-deoxy-D-arabinoheptulosonate 7-phosphate (DAHP) synthase, the 
rate-limiting enzyme of chorismate production, and hence cellular chorismate (Fig. 1)15,16 that is a substrate of 
the PapABC pathway. The enzyme phosphoenolpyruvate (PEP) synthase is used to synthesize cellular PEP that is 
another substrate of shikimate pathway besides E4P. Overexpression of the PEP synthase gene (pps) and both tktA 
and pps did not increase 4APhe production (Fig. 3a), indicating that pps decreased 4APhe production under our 
culture conditions. The PEP-dependent carbohydrate: phosphotransferase system (PTS) is a carbohydrate uptake 
process in E. coli where it is the major consumer of intracellular PEP17. Aiming to eliminate PEP consumption 
by PTS during cellular glucose uptake, we disrupted the ptsHI-crr genes that encode the cytoplasmic compo-
nents of the system. Introducing pET-pfpapA/pCDF-pfpapBC into the gene disruptant resulted in lower 4APhe 
production compared with the corresponding non-disrupted strain (Supplementary Table 3), probably due to a 
decreased rate of glucose uptake.
We overexpressed aroG that encodes DAHP synthase to provide more chorismate for 4APhe production 
(Fig. 1). We used the aroG4fbr gene that encodes a feedback inhibition-resistant (fbr) isozyme of DAHP synthase18. 
The NDPG strain overexpressing aroG4fbr in the NDP strain produced 1.8-fold more 4APhe than the NDP strain in 
flask cultures (Fig. 3a) and this became more obvious when nitrogen sources in the culture medium were increased 
(Supplementary Table 4). Therefore, the following tests included bacteria cultured under these conditions. 
Overexpressing tktA and pps did not increase 4APhe production by the NDPG strain (Supplementary Table 4), 
whereas it increased the production of phenylalanine by a strain sharing the same aroGfbr background15. These 
findings indicate that the amount of DAHP synthase limits bacterial 4APhe production under these conditions. 
We fed-batch cultured NDPG in a jar fermenter and optimized the conditions for 4APhe production. The glucose 
concentration decreased to < 1 g L−1 after 16 h of batch culture and was maintained at this level thereafter to avoid 
repressing T7lac gene promoter activity19 and the metabolic overflow of glucose to acetate that inhibits E. coli 
fermentation20. Fed batch-cultured NDPG generated 4.4 g L−1 4APhe with a production yield of 17% (vs. glucose) 
(Fig. 3b), which represents 62% of the theoretical yield of phenylalanine by E. coli21.
Figure 2. Identification and use of pfpapABC for 4APhe production. (a) Comparison of putative pfpapABC 
gene cluster of P. fluorescens SBW25 and Streptomyces papABC (upper panel). Plasmid organization for 
pfpapBAC expression (lower panel). (b) HPLC chromatograms of culture supernatant of E. coli after culture in 
100 mL of fermentation medium in 500-mL flasks at 30 °C for 30 h. Numbers of introduced plasmids (panel a) 
are shown on traces. (c) Concentration of 4APhe in culture supernatant of E. coli harboring combinations of 
plasmids numbered as in (panel a). Error bars indicate standard deviation (n = 3).
www.nature.com/scientificreports/
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Production of 4APE and 4APAA. The fungal Ehrlich pathway deaminates phenylalanine to phenylpyru-
vate, which phenylpyruvate decarboxylase (PDC) then converts to phenylacetaldehyde. Alcohol dehydrogenase 
(ADH) and aldehyde dehydrogenase (ALDH) reduce and oxidize phenylacetaldehyde to 2-phenylethanol and to 
phenylacetic acid, respectively22. Artificial pathways mimicking the Ehrlich pathway were designed to produce 
4APE and 4APAA (Fig. 1) via pathway enzymes, although a 4-amino-substituted AA has never been assessed 
as an Ehrlich pathway intermediate. We constructed recombinant E. coli BL21 Star (DE3) producing ARO10 
encoding PDC from the fungus S. cerevisiae22, and examined the bioconversion of 4APhe in resting cells. The 
reaction consumed 1.8 g L1 (10 mM) of 4APhe to generate 1.2 g L−1 of 4APE with a 90% molar yield (Table 1), 
implying that PDC efficiently produced 4-aminophenylacetaldehyde, which endogenous E. coli ADH reduced to 
4APE. The resting E. coli BL21 Star (DE3) cells producing both ARO10 and ALDH encoding ALD322 converted 
Figure 3. Metabolic engineering of E. coli to optimize 4APhe production. (a) 4APhe production by E. coli 
NDP expressing pfpapABC cultured in 100 mL of fermentation medium in 500-mL flasks at 30 °C for 30 h. 
Ectopically supplemented genes are shown below. Data are means of three experiments. Error bars indicate 
standard deviation. (b) Fed-batch cultivation of E. coli NDPG strain expressing pfpapABC and aroG4fbr. 
Fermentation medium contained more tryptone and yeast extract (5 and 2.5 g L−1, respectively). Glucose was 
fed to maintain concentration < 1 g L−1. Error bars indicate standard deviation (n = 3).
PDC ALDH
Product (g L−1)
4APAA 4APE
ARO10 – < 0.01 1.2 (0.90)
ARO10 ALD3 0.9 (0.63) 0.4 (0.28)
ARO10 ALD2 1.4 (0.90) 0.1 (0.09)
ARO10 padA 1.3 (0.85) 0.03 (0.01)
PpPDC ALD3 < 0.01 < 0.01
ppdA ALD3 0.4 (0.28) 0.1 (0.10)
Table 1.  Production of 4APAA and 4APE from 4APhe with PDC and ALDH in E. coli. Escherichia coli BL21 
Star (DE3) with pRSF-based plasmid expressed PDC and ALDH genes. Washed cells were incubated in Tris-
HCl (pH 8.5) containing 1.8 g L−1 4APhe at 30 °C for 16 h. Products were measured by HPLC. Production yields 
(vs. 4APhe) are shown in parenthesis. Standard error is < 10%.
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1.8 g L−1 of 4APhe to 0.9 g L−1 of 4APAA with a 63% molar yield (Table 1). The strain produced 0.4 g L−1 4APE 
as a byproduct, indicating that the dehydrogenation of 4-aminophenylacetaldehyde limits 4APAA production. 
Replacing ALD3 with E. coli padA23 and S. cerevisiae ALD222 in the bacterium expressing ARO10 and ALD3 
increased the yields of 4APAA to 85% and 90%, respectively (Table 1). We also combined PDC, Pichia pastoris 
PpARO1024 or Aspergillus oryzae ppdA25 with ALD3, but they produced less 4APAA than those expressing ARO10 
and ALD3 (Table 1). These results indicated that the heterologous expression of ARO10 alone and of the ARO10 
and ALD2 set converted 4APhe to 4APE and APAA the most efficiently. Figure 4a,b shows the time-dependent 
bioconversion of 4APhe (3.6 g L−1) in the optimized systems that produced 2.8 g L−1 4APE and 2.7 g L−1 4APAA.
We expressed ARO10 or both ARO10 and ALD2 in the NDPG strain expressing pfpapABC. The resulting 
NDPGA and NDPGAA strains cultured in fermentation medium produced 4APE, and both 4APAA and 4APE, 
respectively. Production increased linearly until reaching a maximum of 0.24 g L−1 4APE (Fig. 4c), 0.12 g L−1 
4APAA and 0.19 g L−1 4APE (Fig. 4d) at 36 h. These results showed that the cultures fermented glucose to 4APE 
and 4APAA. Both strains accumulated less fermentation products than the intermediate, 4APhe (0.4–1.2 g L−1) 
(Fig. 4c,d). Further optimization of growth parameters or genetic modification could hasten conversion of the 
intermediate and produce more 4APE and 4APAA. Fermentation by the NDPGAA generated 4APE as a byprod-
uct (Fig. 4d), while bioconversion by E. coli BL21 Star (DE3) expressing ARO10 and ALD3 resulted in little 4APE 
production (Fig. 4b), indicating metabolic differences between the strains. These results demonstrated that the 
new bacterial platform can efficiently produce biomass-derived AA.
Production of 4APEA. We examined the reaction of aromatic L-amino acid decarboxylase, which decar-
boxylates phenylalanine to phenylethylamine and carbon dioxide, against 4APhe (Fig. 1). We constructed 
recombinant E. coli BL21 Star (DE3) overexpressing A. oryzae aadA25 and either of the Solanum lycopersicum 
LeAADC1A and LeAADC1B26 genes, both of which encode aromatic L-amino acid decarboxylases. Incubating 
Figure 4. Production of 4APE and 4APAA. (a,b) Bioconversion of 4APhe to 4APE and 4APAA by E. coli BL21 
Star (DE3) harboring either pRSF-aro10 (a) or pRSF-aro10ald2 (b). After incubation with 0.1 mM IPTG, cells 
were washed twice and incubated in reaction buffer containing 3.6 g L−1 4APhe. Error bars indicate standard 
deviation (n = 3). (c, d) HPLC chromatogram of culture supernatant of NDPG harboring pRSF-aro10 (c) and 
pRSF-aro10ald2 (d). Cells were shaken in fermentation medium containing 5 g L−1 tryptone, 2.5 g L−1 yeast 
extract and 10 g L−1 glucose in flasks at 30 °C, induced with 0.1 mM IPTG, and cultured for 36 h.
www.nature.com/scientificreports/
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these cells with 1.8 g L−1 (10 mM) 4APhe efficiently converted 4APhe to 4APEA with 65% to 75% molar yield 
(vs. 4APhe) (Fig. 5a). The strain expressing either LeAADC1A or LeAADC1B produced 4APEA within 4 h. 
We introduced these genes into the NDPG strain, and cultured it in fermentation medium containing 1% glu-
cose. After 42 h, 1.3-fold more 4APEA was accumulated by the strain expressing LeAADC1A than LeAADC1B 
(Fig. 5b), indicating that both strains harboring LeAADC1A converted glucose biomass to 4APEA more effi-
ciently. Fed-batch cultures of the strain expressing LeAADC1A in a jar fermenter generated 1.8 g L−1 4APEA after 
44 h (Fig. 5c). The production yield (vs. glucose) of 4APEA was 5.6%, which was below its theoretical yield (23%) 
calculated from that for phenylalanine (27.5%)21.
Figure 5. Production of 4APEA. (a) Bioconversion of 4APhe to APEA by E. coli harboring pRSF-aadA, pRSF-
leaadc1A, and pRSF-leaadc1B. Cells grown in flasks of LB medium containing 0.1 mM IPTG at 30 °C were 
incubated with 1.8 g L−1 4APhe. Error bars indicate standard deviation (n = 3). (b) Fermentation of 4APEA 
by NDPG harboring pRSF-leaadc1A or pRSF-leaadc1B. Cells were grown at 30 °C in flasks of fermentation 
medium containing 5 g L−1 tryptone and 2.5 g L−1 yeast extract and 0.1 mM IPTG. Error bars indicate standard 
deviation (n = 3). (c) Fed-batch culture of NDPG harboring pRSF-leaadc1A in jar fermenters containing 0.5 L 
of fermentation medium containing 5 g L−1 tryptone and 2.5 g L−1 yeast extract at 30 °C. Adding ammonium 
maintained pH at 7.0. Glucose (0.8 g L−1 h−1) was fed at 16 h after starting culture. Error bars indicate standard 
deviation (n = 3).
www.nature.com/scientificreports/
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Discussion
The aim of constructing microbial platforms to produce various groups of chemicals is to develop specific phar-
maceuticals and biomass-derived materials that can substitute for petroleum chemicals. Most current targets 
for petroleum-based chemicals comprise aliphatic molecules, whereas only aromatic amino acids are fermented 
using glucose biomass as a carbon donor. Glucose is bio-converted into shikimate pathway intermediates27 and 
deoxy-scyllo-inosose28, both of which are chemically derivatized to aromatic compounds such as catechol and its 
related compounds. Bio-derived terephthalic acid has recently been synthesized using biomass-derived isobutanol 
or 5-hydroxymethylfurfral11. These aromatic compounds were generated by combining microbial, with chemical 
reactions. However, we explored biological production systems that do not require chemical processes to produce 
artificial aromatic chemicals, especially those with a substituted nitrogen atom. This is the first bacterial platform 
for the direct fermentative production of a series of AA, and represents a promising environmentally-friendly 
alternative for synthesizing AA building blocks that are applicable to numerous technologies.
This study integrated metabolic engineering strategies to produce AA. Firstly, established strategies for 
high-level fermentation of phenylalanine as well as perturbed metabolic flow of chorismate to phenylalanine 
improved chorismate synthesis by E. coli. Secondly, introducing exogenous papABC genes integrated the intrinsic 
E. coli pathway for chorismate synthesis with the pathway generating aminophenylpyruvate from chorismate, and 
fermented glucose to 4APhe (Fig. 1). We found that papABC is indispensable for AA production and that the P. 
fluorescens papABC identified herein and which originated from a proteobacterium similar to E. coli optimized 
production efficiency. Thirdly, we searched bacteria, fungi and plants for enzymes that produce shikimate path-
way derivatives, and used them to produce 4APEA, 4APE, and 4APAA from a sugar biomass. The production 
rates are sufficient to generate industrial quantities of pharmaceutical intermediates. Fed-batch fermentation pro-
duced optimal amounts of 4APEA (1.8 g L−1), which will be improved by applying traditional strategies such as 
continuous culture and genetically engineering host E. coli metabolism, and 4APEA generated in this manner will 
have potential for bio-material production after a purification process is established.
The platform produced biomass-derived aromatics containing an aniline structure with a substitution at the 
para-position via a C2 chain linked to a functional (amine or carbonyl) group. Such structures have unique 
molecular properties; 4APEA is a diamine connected to rigid aromatic (C6) moiety and flexible C2 chain. This 
and structurally similar bipartite diamines are polymerized with both aliphatic and aromatic dicarboxylic acids to 
generate thermostable polyamides with a considerably high glass-transition temperature29. Polyamide generated 
from 4APEA and isophthalic acid has high thermal stability (Td10 = 360 °C)30. Polycondensation with long flexible 
aliphatic acids generates 4APEA with liquid crystallinity. Furthermore, 4APAA is a C6:C2 compound, and an 
aromatic amino acid. The related 4-aminobenzoic acid (C6:C1) is homopolymerized to form poly(p-benzamide) 
with high thermomechanical properties but its poor solubility and the absence of a melting temperature causes 
difficulties with processing them into plastics. Copolymerizing 4-aminobenzoic acid with 4APAA increases flexi-
bility through the addition of alkyl chains connected to the aromatic rings of poly(p-benzamide)31. This molecular 
design improves processability into heat-resistant filaments, fibers and films31. Thus, the present findings should 
impact the development of novel bio-based aromatic materials.
We developed an AA production platform based on a shikimate pathway variant for synthesizing 4APhe 
(Fig. 1). Although only a small variety of compounds are derived from this pathway in nature, the platform 
produced the artificial 4-amino-substituted compounds 4APAA, 4APE and 4APAE in combination with the 
enzymes for synthesizing their phenylalanine derivatives. Natural derivatives of phenylalanine and its synthetic 
intermediates are more diverse than 4APhe-related compounds, and include cinnamic acid, cinnamyl alcohol, 
cinnamaldehyde, homogentisic acid, phenyllactic acid, mandelic acid, styrene, benzoic acid and other aromatic 
compounds32. We use phenylalanine-deaminating phenylalanine ammonia lyase (Fig. 1) in the bioconversion 
of 4APhe to 4ACA11. Other enzymes that biosynthesize phenylalanine derivatives are potential catalysts in the 
generation of artificial AA, but their synthesis awaits investigation. The constructed platform for AA synthesis has 
the potential to produce bio-derived non-natural AA.
Methods
Bacterial strains and reagents. Supplementary Table 1 lists the strains used in this study. Escherichia coli 
NST37 (ATCC31882) was lysogenized using λ DE3 Lysogenization kits (Novagen, Madison, WI, USA) to gener-
ate NST37 (DE3). We obtained 4APhe from Sigma Aldrich (St. Louis, MO, USA) and 4ACA, 4APE and 4APEA 
from Tokyo Chemical Industry (Tokyo, Japan). Plasmids were constructed using PrimeSTAR HS DNA polymer-
ase and restriction enzymes (Takara Bio Inc., Shiga, Japan).
Constructing plasmids for 4APhe production. Supplementary Table 2 lists the primers used in this 
study. Artificially synthesized, codon-optimized pfpapA, pfpapB and pfpapC (GenScript, NJ, USA) (acces-
sion numbers; KU199222, KU199223, and KU199224) were cloned into pUC57 to generate pUC-pfpapA, 
pUC-pfpapB and pUC-pfpapC, respectively. DNA fragments for pfpapA, pfpapB and pfpapC were amplified by 
PCR using these plasmids and the respective primers sets, PFAF/PFAR, PFBF/PFBR and PFCF/PFCR, and then 
fused by PCR using the primers PFBF and PFCR to generate pfpapBAC fragments. These fragments were digested 
with NdeI and XhoI and cloned into pET22b to generate pET-pfpapBAC. Fragments of pfpapBA were amplified 
by PCR using PFBF and PFAR2 primers and pET-pfpapBAC, digested with NdeI and XhoI, and cloned into 
pET22b to generate pET-pfpapBA. We digested pUC-pfpapA with NdeI and XhoI, and then purified pfpapA 
fragments were cloned into pET-duet1, pCDF-duet1 and pRSF-duet-1 (Novagen) that were digested with the 
same enzymes to generate pET-pfpapA, pCDF-pfpapA and pRSF-pfpapA. We digested pUC-pfpapB with NcoI 
and NotI, and inserted them into the same vectors to generate pET-pfpapB, pCDF-pfpapB and pRSF-papB. 
We digested pUC-pfpapC with NdeI and XhoI and cloned pfpapC fragments into these plasmids to generate 
pET-pfpapBC, pCDF-pfpapBC and pRSF-papBC.
www.nature.com/scientificreports/
8Scientific RepoRts | 6:25764 | DOI: 10.1038/srep25764
Genetic engineering of intrinsic E. coli metabolic pathways. The synthesized DNA fragment aroG4fbr 18 
was cloned into pACYC184 that was digested with EcoRV and HindIII and treated with the Klenow fragment to 
create pACYC-aroG4. The tktA and pps genes were amplified by PCR using E. coli MG1655 total DNA and prim-
ers, digested with NcoI and BamHI, and NdeI and XhoI, and cloned into pRSFduet-1 to generate pRSF-tktA and 
pRSF-pps, respectively. The pps gene was digested with NdeI and XhoI and also cloned into pRSF-tktA to generate 
pRSF-tktApps.
Knock-out cassettes generated by PCR using the primers DpheLAF and DpheLAR, and the Red/ET recom-
bination system (Gene Bridges, Heidelberg, Germany) replaced the genomic pheLA locus of E. coli NST37(DE3) 
with the kanamycin resistance gene (Kmr). The FLP/FRT recombination technique (Gene Bridges) deleted Kmr 
from the strain and generated E. coli NST37(DE3)/Δ pheLA. Diagnostic PCR proceeded using the primers C1 
and C2. Likewise, the ptsHI-crr genes of NST37(DE3)/Δ pheLA were knocked-out using the cassette-generated 
primer pairs DptsHI-crrF and DptsHI-crrR to generate NST37(DE3)/Δ pheLA/Δ ptsHI-crr. Primer pairs C3 and 
C4 was used for diagnostic PCR.
Constructing plasmids for production of other AA. The ARO10 and ALD3 genes were amplified by 
PCR using total DNA from S. cerevisiae and appropriate primers. The ARO10 fragment was digested with NcoI 
and BamHI and cloned into pRSFduet-1 to generate pRSF-aro10. The ALD3 fragment was digested with NdeI 
and XhoI and cloned into pRSFduet-1 and pRSF-aro10 to generate pRSF-ald3 and pRSF-aro10ald3, respectively. 
The S. cerevisiae ALD2 and the E. coli padA genes were amplified using the appropriate primers, digested with 
NdeI and XhoI, and cloned into pRSF-aro10 to generate pRSF-aro10ald2 and pRSF-aro10padA. The PpARO10 
(GenBank accession number, CCA40086.1) gene was amplified by PCR using Pichia pastoris total DNA and 
primers, digested with SacI and NotI, and then cloned into pRSF-ald3 to generate pRSF-pparo10ald3. The A. ory-
zae ppdA was amplified using primers, digested with NcoI and HindIII, and cloned into pRSFduet-1 to generate 
pRSF-ppdA. The NdeI and XhoI fragment of ALD3 was cloned into pRSF-ppdA to generate pRSF-ppdAald3.
Solanum lycopersicum LeAADC1A and LeAADC1B were amplified using its cDNA and the appropriate prim-
ers. The A. oryzae aadA gene was amplified using pET-aadA and the appropriate primers. These DNA fragments 
were digested with BamHI and HindIII, and cloned into pRSFduet-1 to generate pRSF-leaadc1a, pRSF-leaadc1b 
and pRSF-aadA.
Fermentation of 4APhe, 4APAA, 4APE and 4APEA. Cells were grown in the fermentation medium 
comprising 10 g glucose, 2 g tryptone, 1 g yeast extract, 6 g Na2HPO4, 3 g KH2PO4, 0.5 g NaCl, 2 g NH4Cl, 0.5 g 
MgSO4 7H2O, 15 mg CaCl2, 20 mg tyrosine, 20 mg tryptophan, 20 mg phenylalanine, 50 mg thiamine-HCl and 
1 mL of trace element solution/L33. The plasmids were maintained by adding 100 mg L−1 sodium ampicillin, 
40 mg L−1 kanamycin sulfate and 35 mg L−1 chloramphenicol. Recombinant E. coli generated from NST37(DE3)/
Δ pheLA was pre-cultured by rotary shaking at 300 rpm overnight in test tubes containing 5 mL of LB medium 
at 28 °C, and inoculated into 100 mL of fresh M9 medium in 500-mL conical flasks at 1:100 dilution. When the 
cells reached an optical density (OD) of 0.6 at 600 nm and 30 °C, 0.1 mM isopropyl-β -d-thiogalactoside (IPTG) 
was added. After 20–24 h of cultivation the glucose concentration reached < 2 g L−1 and then 2 mL of 500 g L−1 
glucose was added and the cells were further cultured in the flasks for 48 h. Fed-batch cultures were agitated at 
30 °C and 550 rpm in a 1.0-L BMJ-01 fermenter (Biott, Tokyo, Japan) containing 0.5 L of fermentation medium 
supplemented with 5 g L−1 tryptone, 2.5 g L−1 yeast extract, 10 g L−1 (NH4)2SO4 and 10 g L−1 glucose. The culture 
was aerated at 0.6 L min−1. When the OD reached 0.6 at 600 nm, 0.1 mM IPTG was added. Peristaltic pumps fed 
the cultures with 500 g L−1 of glucose and 0.1 mM IPTG when the glucose concentration dipped below 1.5 g L−1. 
The pH was monitored using an electrode and maintained between 7.0 and 7.1 by adding 10% NH4OH.
Bioconversion by resting cells. Escherichia coli BL21 Star (DE3) (Invitrogen, Carlsbad, CA, USA) har-
boring expression plasmids was rotary shaken at 300 rpm and 30 °C overnight in test tubes containing 3 mL 
of LB medium and inoculated into 500-mL conical flasks containing 100 mL LB medium at a 1:100 dilution. 
When the cells reached an OD of 0.6 at 600 nm and 30 °C, 0.1 mM IPTG was added. Cells harboring pRSF-aro10, 
pRSF-aro10ald3, pRSF-aro10ald2 or pRSF-aro10padA were further incubated at 30 °C for 6 h. The cells were col-
lected by centrifugation at 5,000 × g for 10 min and washed with DCD buffer (100 mM KH2PO4 (pH 7.5), 1 mM 
MgSO4, 0.5 mM thiamine chloride). Cells harboring pRSF-leaadc1a, pRSF-leaadc1b or pRSF-aadA were further 
incubated at 16 °C for 12 h with 0.5 mM pyridoxal 5-phosphate, washed with AAD buffer (100 mM potassium 
phosphate, pH 7.5 and 0.5 mM pyridoxal 5-phosphate). The washed cells were incubated in 10 mL of DCD or 
AAD buffer containing the indicated amounts of 4APhe at 28 °C and shaken at 300 rpm for the indicated periods.
Determination of metabolites. We determined yields of 4APhe, 4APA, 4APE and 4APEA by 
high-performance liquid chromatography (HPLC) using a 1200 infinity series (Agilent Technologies, Palo Alto, 
CA, USA) equipped with a 250 × 4.6-mm Purospher Star RP-18 end-capped column with a particle size of 5 μ m 
(Millipore-Merck, Billerica, MA, USA). The initial mobile phase was solvent A:solvent B = 98:2 (solvent A, 20 mM 
potassium phosphate (pH 7.0); solvent B, methanol) and maintained for 7 min. The concentration of solvent B 
was increased to 50% for 5 min and then maintained at that ratio for another 5 min. The flow rate was 0.8 mL 
min−1, and absorption at 210 nm was monitored. Glucose concentrations were determined using glucose-CII test 
kit (Wako, Tokyo, Japan).
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